Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial

RANGE study investigators

Research output: Contribution to journalArticlepeer-review

119 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences